Allergic Airway Inflammation and Susceptibility to Pneumonia

Does atopy affect the course of pneumonia? Allergic Airway Inflammation and Susceptibility to Pneumonia

Widodo Judarwanto, pediatrician

The presence of atopy is considered as a risk factor for severe respiratory symptoms in children. The objective of this study was to examine the effect of atopy on the course of disease in children hospitalised with viral pneumonia. The relationship between allergic airway inflammation and pneumococcal pneumonia is not well understood.

Kang et all studied susceptibility to experimental pneumococcal pneumonia in mice with and without allergic airway inflammation. Susceptibility to pneumococcal pneumonia was evaluated by challenging mice with a bioluminescent Streptococcus pneumoniae strain after sensitization with ovalbumin (OVA), with subsequent monitoring of pneumococcal infection using real-time photonic imaging. Of 46 OVA-sensitized mice challenged with pneumococci, 13 (28%) developed imaging findings consistent with pneumococcal pneumonia. In comparison, 28 (57%) of 49 non-sensitized control mice developed pneumococcal pneumonia (P = 0·005). While none of the control group developed meningitis (0%, none of 28), two mice in the OVA-sensitized group developed meningitis (15·4%, two of 13) (P = 0·09). The mean bacterial count in the lung was significantly lower in the OVA-sensitized than the non-sensitized group (8·26 ± 0·69 versus 9·21 ± 0·67 log10 colony-forming units (CFU)/g, P = 0·002). There was a trend towards the mean bacterial count in the spleen being higher in the OVA-sensitized versus the non-sensitized group (8·14 ± 0·89 versus 7·45 ± 1·07 log10 CFU/g, P = 0·071). A high level of interleukin (IL)-4 in lung homogenates was associated with risk of pneumococcal infection independent of sensitization with OVA (odds ratio: 49·7, 95% confidence interval 2·92-846·5, per increment of 1·0 pg/ml). In the murine model studied, acute allergic airway inflammation reduced susceptibility to pneumococcal pneumonia. IL-4 may increase the risk of pneumococcal pneumonia independently of allergic airway inflammation.

Talbot et al.reported recently that asthma is associated with an increased risk of IPD among Medicaid recipients of the state of Tennessee. This study finding was confirmed independently in our recent study in Rochester, Minnesota. Higher rates of pneumococcal nasopharyngeal colonization as well as sinusitis and otitis media have been reported among individuals with asthma. The Advisory Committee on Immunization Practices has recommended recently that adults with asthma receive the pneumococcal vaccine. The mechanisms underlying the above observations are unknown. T helper type 2 (Th2)-predominant immune responses to various environmental stimuli play a role in the development and exacerbation of atopic diseases, including asthma. Numerous studies demonstrate that Th2 cytokines [e.g. interleukin (IL)-4)] down-regulate Th1 functions; this has been suggested to be associated with susceptibility to and severity of protozoal, mycoplasmaa, bacterial, viral and candidal infections. Despite evidence that Th2 cytokines increase susceptibility to these infections, whether Th2 immune responses (i.e increased Th2 cytokines or reciprocal counter-regulation of Th1 cytokines) influence susceptibility to IPD is unknown.

Erdem et all reported children between the ages of 1 and 6 years hospitalised due to viral pneumonia between the years of 2013 and 2016 were included to this multicentre study. Patients were classified into two groups as mild-moderate and severe according to the course of pneumonia. Presence of atopy was evaluated with skin prick tests. Groups were compared to evaluate the risk factors associated with severe viral pneumonia. A total of 280 patients from nine centres were included in the study. Of these patients, 163 (58.2%) were male. Respiratory syncytial virus (29.7%), Influenza A (20.5%), rhinovirus (18.9%), adenovirus (10%), human metapneumovirus (8%), parainfluenza (5.2%), coronavirus (6%), and bocavirus (1.6%) were isolated from respiratory samples. Eighty-five (30.4%) children had severe pneumonia. Atopic sensitisation was found in 21.4% of the patients. Ever wheezing (RR: 1.6, 95% CI: 1.1-2.4), parental asthma (RR: 1.5, 95% CI: 1.1-2.2), other allergic diseases in the family (RR: 1.8, 95% CI: 1.2-2.9) and environmental tobacco smoke (RR: 1.6, 95% CI: 1.1-3.5) were more common in the severe pneumonia group. When patients with mild-moderate pneumonia were compared to patients with severe pneumonia, frequency of atopy was not different between the two groups. However, parental asthma, ever wheezing and environmental tobacco smoke exposure are risk factors for severe viral pneumonia in children.

References:

  • Erdem SB1, Can D2, Girit S3, Çatal F4, Şen V5, Pekcan S6, Yüksel H7, Bingöl A8, Bostancı I9, Erge D10, Ersu R11. Does atopy affect the course of viral pneumonia?. Allergol Immunopathol (Madr). 2018 Mar – Apr;46(2):119-126. doi: 10.1016/j.aller.2017.04.003. Epub 2017 Jun 17.
  • Kang CI, Rouse MS, Patel R, Kita H, Juhn YJ. Allergic airway inflammation and susceptibility to pneumococcal pneumonia in a murine model with real-time in vivo evaluation. Clin Exp Immunol. 2009;156(3):552–561. doi:10.1111/j.1365-2249.2009.03925.x
  • Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352:2082–90.
  • Juhn YJ, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008;122:719–23.
  • Cernelc D, Gerbec M, Cernelc P. Comparative study of virological infections in asthmatic and nonasthmatic children. Acta Allergol. 1975;30:423–33.
  • Eldeirawi K, Persky VW. History of ear infections and prevalence of asthma in a national sample of children aged 2 to 11 years: the Third National Health and Nutrition Examination Survey, 1988 to 1994. Chest. 2004;125:1685–92.
  • Centers for Disease Control and Prevention (CDC) ACIP provisional recommendations for use of pneumococcal vaccines. [accessed 12 March 2009]. Available at: http://www.cdc.gov/vaccines/recs/provisional/downloads/pneumo-oct-2008-508.pdf.
  • Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383:787–93.
  • Smart JM, Kemp AS. Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy. 2002;32:796–802.
  • Chaplin D. Clearance of Mycoplasma pneumoniae is impaired in mice with established allergic airway inflammation. J Allergy Clin Immunol. 2007;119:S132.
  • Chu HW, Thaikoottathil J, Rino JG, et al. Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. J Immunol. 2007;179:3995–4002.

Tinggalkan Balasan

Isikan data di bawah atau klik salah satu ikon untuk log in:

Logo WordPress.com

You are commenting using your WordPress.com account. Logout /  Ubah )

Foto Google

You are commenting using your Google account. Logout /  Ubah )

Gambar Twitter

You are commenting using your Twitter account. Logout /  Ubah )

Foto Facebook

You are commenting using your Facebook account. Logout /  Ubah )

Connecting to %s